Should all adults be considered for statin therapy? A closer look at the arguments for and against the latest changes to National Institute for Health and Care Excellence guidelines for statin therapy.…
Oral HRT accepted for use across Scotland while availability remains limited in England Bijuve has been been approved for use across Scotland, but it is only available in some local formularies in England, owing to backlogs caused by COVID-19.…
Appetite suppressant approved by NICE for patients with obesity The National Institute for Health and Care Excellence recommends that semaglutide should be considered in adults with at least one weight-related condition and a body mass index of at least 35.…
Cannabis-based Sativex approved for NHS use in Scotland The Scottish Medicines Consortium's decision to approve Sativex brings it in line with the rest of the UK.…
Updated NICE guidance for type 2 diabetes: what do you need to know? In this episode of the PJ Pod, we explore the main changes and implications for practice brought about by the National Institute for Health and Care Excellence update to the ‘Type 2 diabetes in adults: management’ guideline.…
NICE to approve icosapent ethyl for some high-risk cardiovascular patients The National Institute for Health and Care Excellence says 425,000 people with established cardiovascular disease could benefit from treatment with icosapent ethyl.…
NICE has ‘failed to listen to patient evidence’ on prescription drug withdrawal, claims parliamentary group The All-Party Parliamentary Group for Prescribed Drug Dependence has criticised the National Institute for Health and Care Excellence on its new guidance on tapered withdrawal of dependency-forming drugs.…
NICE recommends continuous glucose monitoring for all patients with type 1 diabetes Patients will now have a choice in picking the technology that is right for them based on their individual preferences and needs.…
NICE removes budesonide from recommended COVID-19 treatments In updated guidance, the National Institute for Health and Care Excellence said there was “no statistically significant difference” between patients treated with inhaled budesonide for COVID-19 and those who received usual care.…
NICE draft guidance on medicines associated with dependence could be ‘harmful’, warns RPS The Royal Pharmaceutical Society's response to a consultation says guidance on “slow tapering” is “open to too much interpretation”.…